News Asbestos Exposure
Paying tribute to one of country’s leading thoracic surgeons and mesothelioma expert, Dr. David Sugarbaker
August 31, 2018 | by: Motley Rice
World-renowned thoracic surgeon and pleural mesothelioma specialist David J. Sugarbaker, M.D. died Wednesday, August 29.
News Motley Rice - Firm Wide
Motley Rice attorneys recognized by Best Lawyers®
August 17, 2018 | by: Motley Rice
We are proud to announce that 16 Motley Rice member attorneys are included in The Best Lawyers in America© 2019.
News Antitrust
Motley Rice appointed co-lead counsel on Zetia antitrust litigation
August 16, 2018 | by: Motley Rice
Motley Rice attorney Michael Buchman has been appointed Interim Co-Lead Counsel for the In re Zetia Antitrust Litigation, in which the End-Payor Plaintiffs allege Merck & Co. Inc., conspired with at least one other generic drug maker to delay Zetia generic market entry.
Blog Asbestos Exposure
Summer School: The prevalence of asbestos in schools | Causes, Not Just Cases®
August 13, 2018 | by: T. David Hoyle
Teachers, students and school staff across the nation work and study in buildings containing asbestos, leaving them at a higher risk of asbestos exposure and related diseases, including mesothelioma.
News Aviation Lawsuit
Aeromexico plane crashes after takeoff in Mexico
August 2, 2018 | by: Motley Rice
An Aeromexico airline flight crashed near Durango, Mexico, injuring at least 97 people according to early estimates. 103 passengers and 4 crew members were on board the Embraer 190 aircraft.
Blog Medical Device Lawsuits | Women’s Health Lawsuits
Top 4 things to know about Bayer stopping Essure sales | Causes, Not Just Cases®
July 31, 2018 | by: Fidelma L. Fitzpatrick
This news is particularly significant because it is quite rare that a medical device manufacturer completely stops sales of a device following complaints. As lead counsel for Essure litigation coordinated in California state court, I know many women and their loved ones who have questions about what this means. Here…
News Antitrust
$54 million anti-trust settlement approved for Aggrenox end-payor plaintiffs
July 31, 2018 | by: Motley Rice
Motley Rice reached an anti-trust settlement to resolve litigation alleging drug manufacturers Boehringer Ingelheim and Teva Pharmaceutical engaged in an alleged pay-for-delay scheme to block generic competition for stroke medication Aggrenox®.
News Securities Class Actions
Motley Rice reaches $43 million settlement with Medtronic on behalf of investors
July 31, 2018 | by: Motley Rice
Motley Rice reached a $43 million settlement with Medtronic, Inc. on behalf of shareholders who purchased the company’s common stock and suffered losses.
News Consumer Fraud Protection
Mathew Jasinski named “New Leader in Law” by The Connecticut Law Tribune
July 27, 2018 | by: Motley Rice
The Connecticut Law Tribune has recognized Motley Rice consumer fraud attorney Mathew Jasinski as a “New Leader in Law” for 2018.
News Motley Rice - Firm Wide
Motley Rice a finalist in four “Elite Trial Lawyers” categories
July 27, 2018 | by: Motley Rice
The National Law Journal announced finalists for its 2018 Elite Trial Lawyers and has named Motley Rice a finalist in four categories for its “exemplary performance in cutting edge work.”